MedTrace Logo

Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone

NCT02567552 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-12-16

Study results available
· View outcomes & findings →

Summary

Study the endometrial predecidualization by using subcutaneous progesterone 25 mg/day versus intramuscular progesterone 50 mg/day, to determine whether there are differences in the endometrial transformation and endometrial receptivity.

Conditions

  • Reproductive Techniques, Assisted

Interventions

DRUG

Subcutaneous progesterone

subcutaneous progesterone 25 mg/day

DRUG

Intramuscular progesterone

intramuscular progesterone 50 mg/day

Sponsors & Collaborators

  • IVI Barcelona

    lead OTHER

Principal Investigators

  • Agustín B Boluda · IVI Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
34 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02567552 on ClinicalTrials.gov